← Alle mensen

NF

Naoki Furuya

7 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 augustus 2025

Pragmatic Gerandomiseerde Study of Afatinib Versus Chemotherapy for Patiënten met Non-Small Cell Lung Cancer With Unc...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 juni 2025

NSCLC met driveralteraties: ASCO Living Guideline 2024.1

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2024

NSCLC zonder driveralteraties: ASCO Living Guideline 2024.1

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2024

Nivolumab versus nivolumab plus docetaxel bij eerder behandeld NSCLC: fase II

Clinical cancer research : an official journal of the American Association for Cancer Research · 14 oktober 2022

Osimertinib plus bevacizumab versus osimertinib bij T790M NSCLC

JAMA oncology · 1 maart 2021

Erlotinib plus bevacizumab versus erlotinib bij EGFR-positief NSCLC: NEJ026 fase III

The Lancet. Oncology · 2019-05